淋巴结阳性-话题@MedSci

#淋巴结阳性#

19篇内容 | 817人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1509998, encodeId=97aa1509998ca, content=<a href='/topic/show?id=735366030db' target=_blank style='color:#2F92EE;'>#淋巴结阳性#</a>, objectTitle=Thorac Cancer:淋巴结阳性(cN+)和阴性(cN0)的I期NSCLC患者术后无病生存(DFS)差异, objectType=article, longId=727693, objectId=a4d6e2769330, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4d6e2769330, replyNumber=0, likeNumber=20, createdTime=2022-05-25, rootId=0, userName=aids216, userId=590210187011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4d6e2769330, moduleTitle=Thorac Cancer:淋巴结阳性(cN+)和阴性(cN0)的I期NSCLC患者术后无病生存(DFS)差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a4d6e2769330)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509997, encodeId=28ae150999eea, content=<a href='/topic/show?id=735366030db' target=_blank style='color:#2F92EE;'>#淋巴结阳性#</a>, objectTitle=NEJM：21基因检测为淋巴结阳性乳腺癌患者化疗获益提供了预后信息, objectType=article, longId=292084, objectId=0ea6292084db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ea6292084db, replyNumber=0, likeNumber=32, createdTime=2021-12-18, rootId=0, userName=aids216, userId=590210187011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ea6292084db, moduleTitle=NEJM：21基因检测为淋巴结阳性乳腺癌患者化疗获益提供了预后信息, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ea6292084db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509996, encodeId=dffb150999658, content=<a href='/topic/show?id=735366030db' target=_blank style='color:#2F92EE;'>#淋巴结阳性#</a>, objectTitle=NEJM：绝经状态会影响腋窝淋巴结阳性乳腺癌患者化疗-内分泌联合治疗收益, objectType=article, longId=221513, objectId=0627221513f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0627221513f9, replyNumber=0, likeNumber=38, createdTime=2021-12-05, rootId=0, userName=aids216, userId=590210187011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0627221513f9, moduleTitle=NEJM：绝经状态会影响腋窝淋巴结阳性乳腺癌患者化疗-内分泌联合治疗收益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0627221513f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509995, encodeId=770c15099953e, content=<a href='/topic/show?id=735366030db' target=_blank style='color:#2F92EE;'>#淋巴结阳性#</a>, objectTitle=Front Oncol：ER+/HER2-且淋巴结阳性的绝经前乳腺癌患者，新辅助化疗（NCT）对比新辅助内分泌治疗（NET）的疗效：III期临床研究NEST , objectType=article, longId=218140, objectId=973121814015, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=973121814015, replyNumber=0, likeNumber=28, createdTime=2021-10-07, rootId=0, userName=aids216, userId=590210187011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=973121814015, moduleTitle=Front Oncol：ER+/HER2-且淋巴结阳性的绝经前乳腺癌患者，新辅助化疗（NCT）对比新辅助内分泌治疗（NET）的疗效：III期临床研究NEST , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=973121814015)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509994, encodeId=c9cc1509994a5, content=<a href='/topic/show?id=735366030db' target=_blank style='color:#2F92EE;'>#淋巴结阳性#</a>, objectTitle=J Clin Oncol：Abemaciclib联合内分泌疗法治疗HR+HER2-淋巴结阳性高风险乳腺癌, objectType=article, longId=201057, objectId=ce9520105e86, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce9520105e86, replyNumber=0, likeNumber=17, createdTime=2020-09-24, rootId=0, userName=aids216, userId=590210187011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce9520105e86, moduleTitle=J Clin Oncol：Abemaciclib联合内分泌疗法治疗HR+HER2-淋巴结阳性高风险乳腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce9520105e86)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509993, encodeId=4a2e15099936a, content=<a href='/topic/show?id=735366030db' target=_blank style='color:#2F92EE;'>#淋巴结阳性#</a>, objectTitle=2019 FROGG建议：淋巴结阳性前列腺癌的放射治疗, objectType=article, longId=168620, objectId=06de168620cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06de168620cb, replyNumber=0, likeNumber=18, createdTime=2019-06-18, rootId=0, userName=aids216, userId=590210187011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06de168620cb, moduleTitle=2019 FROGG建议：淋巴结阳性前列腺癌的放射治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=06de168620cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509992, encodeId=1aaa150999290, content=<a href='/topic/show?id=735366030db' target=_blank style='color:#2F92EE;'>#淋巴结阳性#</a>, objectTitle=JCO：淋巴结阳性乳腺癌患者辅助化疗不宜联合贝伐单抗, objectType=article, longId=145415, objectId=a95d145415a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a95d145415a6, replyNumber=0, likeNumber=29, createdTime=2018-07-30, rootId=0, userName=aids216, userId=590210187011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a95d145415a6, moduleTitle=JCO：淋巴结阳性乳腺癌患者辅助化疗不宜联合贝伐单抗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a95d145415a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509991, encodeId=806a15099919e, content=<a href='/topic/show?id=735366030db' target=_blank style='color:#2F92EE;'>#淋巴结阳性#</a>, objectTitle=JAMA Oncol：乳腺癌伴腋窝淋巴结阳性患者的诊疗推荐（2017）, objectType=article, longId=124001, objectId=ace6124001a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ace6124001a1, replyNumber=0, likeNumber=29, createdTime=2017-12-21, rootId=0, userName=aids216, userId=590210187011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ace6124001a1, moduleTitle=JAMA Oncol：乳腺癌伴腋窝淋巴结阳性患者的诊疗推荐（2017）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ace6124001a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509990, encodeId=d25915099902f, content=<a href='/topic/show?id=735366030db' target=_blank style='color:#2F92EE;'>#淋巴结阳性#</a>, objectTitle=Eur Urol：淋巴结阳性前列腺癌患者根治性前列腺切除术后生存结局：不同术后管理策略的比较分析。, objectType=article, longId=116266, objectId=46a611626622, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=46a611626622, replyNumber=0, likeNumber=30, createdTime=2017-10-17, rootId=0, userName=aids216, userId=590210187011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=46a611626622, moduleTitle=Eur Urol：淋巴结阳性前列腺癌患者根治性前列腺切除术后生存结局：不同术后管理策略的比较分析。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=46a611626622)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509989, encodeId=9d9e150998954, content=<a href='/topic/show?id=735366030db' target=_blank style='color:#2F92EE;'>#淋巴结阳性#</a>, objectTitle=Eur Urol：局部疗法对初诊时盆腔淋巴结阳性的前列腺癌患者的疗效。, objectType=article, longId=113026, objectId=6d8a113026ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d8a113026ec, replyNumber=0, likeNumber=25, createdTime=2017-09-18, rootId=0, userName=aids216, userId=590210187011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d8a113026ec, moduleTitle=Eur Urol：局部疗法对初诊时盆腔淋巴结阳性的前列腺癌患者的疗效。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d8a113026ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509988, encodeId=cbfe15099882f, content=<a href='/topic/show?id=735366030db' target=_blank style='color:#2F92EE;'>#淋巴结阳性#</a>, objectTitle=2017 多机构治疗建议：复发淋巴结阳性非小细胞肺癌1期疾病立体定向放射治疗后再照射治疗, objectType=article, longId=106865, objectId=ef6e106865dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef6e106865dd, replyNumber=0, likeNumber=21, createdTime=2017-07-28, rootId=0, userName=aids216, userId=590210187011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef6e106865dd, moduleTitle=2017 多机构治疗建议：复发淋巴结阳性非小细胞肺癌1期疾病立体定向放射治疗后再照射治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef6e106865dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509987, encodeId=9403150998efb, content=<a href='/topic/show?id=735366030db' target=_blank style='color:#2F92EE;'>#淋巴结阳性#</a>, objectTitle=Int J Gynecol Cancer：淋巴结阳性的早期子宫颈癌的治疗, objectType=article, longId=104322, objectId=ca24104322df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca24104322df, replyNumber=0, likeNumber=31, createdTime=2017-07-04, rootId=0, userName=aids216, userId=590210187011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca24104322df, moduleTitle=Int J Gynecol Cancer：淋巴结阳性的早期子宫颈癌的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca24104322df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509986, encodeId=dd021509986cc, content=<a href='/topic/show?id=735366030db' target=_blank style='color:#2F92EE;'>#淋巴结阳性#</a>, objectTitle=JNCI：在早期阶段直肠癌患者中，低龄化增加了淋巴结阳性的风险, objectType=article, longId=62510, objectId=28416251020, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28416251020, replyNumber=0, likeNumber=25, createdTime=2016-01-25, rootId=0, userName=aids216, userId=590210187011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28416251020, moduleTitle=JNCI：在早期阶段直肠癌患者中，低龄化增加了淋巴结阳性的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28416251020)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509985, encodeId=dcc9150998579, content=<a href='/topic/show?id=735366030db' target=_blank style='color:#2F92EE;'>#淋巴结阳性#</a>, objectTitle=J Natl Cancer Inst：“年轻”会导致直肠癌患者淋巴结阳性风险加大, objectType=article, longId=62146, objectId=5bf5621463a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5bf5621463a, replyNumber=0, likeNumber=32, createdTime=2016-01-16, rootId=0, userName=aids216, userId=590210187011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5bf5621463a, moduleTitle=J Natl Cancer Inst：“年轻”会导致直肠癌患者淋巴结阳性风险加大, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5bf5621463a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509984, encodeId=5d0e1509984f8, content=<a href='/topic/show?id=735366030db' target=_blank style='color:#2F92EE;'>#淋巴结阳性#</a>, objectTitle=ASCO 2014：对比6周期ET与8周期EC-T治疗腋窝淋巴结阳性的乳腺癌患者的疗效, objectType=article, longId=35697, objectId=2f1b3569e18, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f1b3569e18, replyNumber=0, likeNumber=45, createdTime=2014-06-02, rootId=0, userName=aids216, userId=590210187011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f1b3569e18, moduleTitle=ASCO 2014：对比6周期ET与8周期EC-T治疗腋窝淋巴结阳性的乳腺癌患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f1b3569e18)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509983, encodeId=6d6a1509983ec, content=<a href='/topic/show?id=735366030db' target=_blank style='color:#2F92EE;'>#淋巴结阳性#</a>, objectTitle=JCO：伊班膦酸钠辅助治疗早期淋巴结阳性乳腺癌无生存获益, objectType=article, longId=24036, objectId=4d552403677, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d552403677, replyNumber=0, likeNumber=25, createdTime=2013-09-08, rootId=0, userName=aids216, userId=590210187011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d552403677, moduleTitle=JCO：伊班膦酸钠辅助治疗早期淋巴结阳性乳腺癌无生存获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d552403677)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509982, encodeId=bb60150998211, content=<a href='/topic/show?id=735366030db' target=_blank style='color:#2F92EE;'>#淋巴结阳性#</a>, objectTitle=JAMA Surg：非前哨淋巴结阳性或为黑色素瘤不良预后的预测因子, objectType=article, longId=22776, objectId=108022e76b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=108022e76b3, replyNumber=0, likeNumber=33, createdTime=2013-08-10, rootId=0, userName=aids216, userId=590210187011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=108022e76b3, moduleTitle=JAMA Surg：非前哨淋巴结阳性或为黑色素瘤不良预后的预测因子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=108022e76b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509981, encodeId=2e221509981c3, content=<a href='/topic/show?id=735366030db' target=_blank style='color:#2F92EE;'>#淋巴结阳性#</a>, objectTitle=淋巴结阳性胃癌患者生存率与放疗有关, objectType=article, longId=6597, objectId=ea3e659e42, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea3e659e42, replyNumber=0, likeNumber=43, createdTime=2012-05-27, rootId=0, userName=aids216, userId=590210187011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea3e659e42, moduleTitle=淋巴结阳性胃癌患者生存率与放疗有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea3e659e42)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509980, encodeId=2f341509980d9, content=<a href='/topic/show?id=735366030db' target=_blank style='color:#2F92EE;'>#淋巴结阳性#</a>, objectTitle=前哨淋巴结阳性乳腺癌新辅助化疗后淋巴引流区辅助放疗的意义, objectType=article, longId=3296, objectId=87293296e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87293296e3, replyNumber=0, likeNumber=24, createdTime=2011-11-14, rootId=0, userName=aids216, userId=590210187011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87293296e3, moduleTitle=前哨淋巴结阳性乳腺癌新辅助化疗后淋巴引流区辅助放疗的意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87293296e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

淋巴结阳性

2020-05-29

aids216 (审核中...)

前往app查看评论内容

#淋巴结阳性#

Thorac Cancer:淋巴结阳性(cN+)和阴性(cN0)的I期NSCLC患者术后无病生存(DFS)差异

2022-05-25

aids216 (审核中...)

前往app查看评论内容

#淋巴结阳性#

NEJM：21基因检测为淋巴结阳性乳腺癌患者化疗获益提供了预后信息

2021-12-18

aids216 (审核中...)

前往app查看评论内容

#淋巴结阳性#

NEJM：绝经状态会影响腋窝淋巴结阳性乳腺癌患者化疗-内分泌联合治疗收益

2021-12-05

aids216 (审核中...)

前往app查看评论内容

#淋巴结阳性#

Front Oncol：ER+/HER2-且淋巴结阳性的绝经前乳腺癌患者，新辅助化疗（NCT）对比新辅助内分泌治疗（NET）的疗效：III期临床研究NEST

2021-10-07

aids216 (审核中...)

前往app查看评论内容

#淋巴结阳性#

J Clin Oncol：Abemaciclib联合内分泌疗法治疗HR+HER2-淋巴结阳性高风险乳腺癌

2020-09-24

aids216 (审核中...)

前往app查看评论内容

#淋巴结阳性#

2019 FROGG建议：淋巴结阳性前列腺癌的放射治疗

2019-06-18

aids216 (审核中...)

前往app查看评论内容

#淋巴结阳性#

JCO：淋巴结阳性乳腺癌患者辅助化疗不宜联合贝伐单抗

2018-07-30

aids216 (审核中...)

前往app查看评论内容

#淋巴结阳性#

JAMA Oncol：乳腺癌伴腋窝淋巴结阳性患者的诊疗推荐（2017）

2017-12-21

aids216 (审核中...)

前往app查看评论内容

#淋巴结阳性#

Eur Urol：淋巴结阳性前列腺癌患者根治性前列腺切除术后生存结局：不同术后管理策略的比较分析。

2017-10-17

aids216 (审核中...)

前往app查看评论内容

#淋巴结阳性#

Eur Urol：局部疗法对初诊时盆腔淋巴结阳性的前列腺癌患者的疗效。

2017-09-18

aids216 (审核中...)

前往app查看评论内容

#淋巴结阳性#

2017 多机构治疗建议：复发淋巴结阳性非小细胞肺癌1期疾病立体定向放射治疗后再照射治疗

2017-07-28

aids216 (审核中...)

前往app查看评论内容

#淋巴结阳性#

Int J Gynecol Cancer：淋巴结阳性的早期子宫颈癌的治疗

2017-07-04

aids216 (审核中...)

前往app查看评论内容

#淋巴结阳性#

JNCI：在早期阶段直肠癌患者中，低龄化增加了淋巴结阳性的风险

2016-01-25

aids216 (审核中...)

前往app查看评论内容

#淋巴结阳性#

J Natl Cancer Inst：“年轻”会导致直肠癌患者淋巴结阳性风险加大

2016-01-16

aids216 (审核中...)

前往app查看评论内容

#淋巴结阳性#

ASCO 2014：对比6周期ET与8周期EC-T治疗腋窝淋巴结阳性的乳腺癌患者的疗效

2014-06-02

aids216 (审核中...)

前往app查看评论内容

#淋巴结阳性#

JCO：伊班膦酸钠辅助治疗早期淋巴结阳性乳腺癌无生存获益

2013-09-08

aids216 (审核中...)

前往app查看评论内容

#淋巴结阳性#

JAMA Surg：非前哨淋巴结阳性或为黑色素瘤不良预后的预测因子

2013-08-10

aids216 (审核中...)

前往app查看评论内容

#淋巴结阳性#

淋巴结阳性胃癌患者生存率与放疗有关

2012-05-27

aids216 (审核中...)

前往app查看评论内容

#淋巴结阳性#

前哨淋巴结阳性乳腺癌新辅助化疗后淋巴引流区辅助放疗的意义

2011-11-14

科室
- - 订阅+
  - 更多科室
工具
服务